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ABSTRACT The interaction of colicins with target cells is a paradigm for protein import. To enter cells, bactericidal colicins
parasitize Escherichia coli outer membrane receptors whose physiological purpose is the import of essential metabolites.
Colicins E1 and E3 initially bind to the BtuB receptor, whose b-barrel pore is occluded by an N-terminal globular ‘‘plug’’. The x-ray
structure of a complex of BtuB with the coiled-coil BtuB-binding domain of colicin E3 did not reveal displacement of the BtuB plug
that would allow passage of the colicin (Kurisu, G., S. D. Zakharov, M. V. Zhalnina, S. Bano, V. Y. Eroukova, T. I. Rokitskaya, Y.
N. Antonenko, M. C. Wiener, and W. A. Cramer. 2003. Nat. Struct. Biol. 10:948–954). This correlates with the inability of BtuB to
form ion channels in planar bilayers, shown in this work, suggesting that an additional outer membrane protein(s) is required for
colicin import across the outer membrane. The identity and interaction properties of this OMP were analyzed in planar bilayer
experiments. OmpF and TolC channels in planar bilayers were occluded by colicins E3 and E1, respectively, from the trans-side
of the membrane. Occlusion was dependent upon a cis-negative transmembrane potential. A positive potential reversibly opened
OmpF and TolC channels. Colicin N, which uses only OmpF for entry, occludes OmpF in planar bilayers with the same orientation
constraints as colicins E1 and E3. The OmpF recognition sites of colicins E3 and N, and the TolC recognition site of colicin E1,
were found to reside in the N-terminal translocation domains. These data are considered in the context of a two-receptor
translocon model for colicin entry into cells.
INTRODUCTION
Cellular import of cytotoxic colicins requires translocation
across the outer membrane and periplasmic space of
Escherichia coli and insertion into, or transfer across, the
cytoplasmic membrane, as discussed and reviewed else-
where (Lazdunski et al., 1998; James et al., 2002; Zakharov
and Cramer, 2004). In this pathway, the multidomain
colicins of groups A and B use the Tol and Ton translocation
routes, respectively (Braun et al., 2002; Lazzaroni et al.,
2002). The initial step of the import is recognition by and
binding to outer membrane receptors. For this purpose, most
colicins of group A use the vitamin B12 (cobalamin) receptor,
BtuB (Fig. 1 A) (Chimento et al., 2003; Kurisu et al., 2003).
It belongs to the family of OM receptors of gram-negative
bacteria that are 22-strand b-barrel proteins, whose physi-
ological purpose is the accumulation of metals (e.g., Fe, Co)
and metabolites (e.g., vitamin B12). The b-barrels of these
receptors are ‘‘plugged’’ by 130–150 residue N-terminal
globular domains that have extensive interactions with the
strands of the b-barrel (Ferguson and Deisenhofer, 2002).
OmpF (Fig. 1 B) and TolC (Fig. 1 C) form stable trimers in
the bacterial outer membrane. Every monomer in the OmpF
trimer is capable of forming an ion-permeable channel that is
slightly cation-selective (Benz et al., 1985; Alcaraz et al.,
2004). OmpF is a 16-stranded b-barrel protein with its pore
partially occluded by a long external loop L3 (Fig. 1 B;
Cowan et al., 1992). It is required, in addition to BtuB, for the
activity of many group A colicins (Cavard and Lazdunski,
1981; Chai et al., 1982; Benedetti et al., 1989). The combined
contribution of BtuB and TolC is required for the activity of
colicin E1 (Nagel de Zwaig and Luria, 1967; Davies and
Reeves, 1975). OmpF alone is required for the activity of
colicin N (Bourdineaud et al., 1990; Fourel et al., 1990; El
Kouhen et al., 1993). TolC is a trimeric protein embedded in
the outer membrane by its b-barrel (Fig. 1 C), and spans the
periplasmic space as an a-helical ‘‘tunnel’’ (Koronakis et al.,
2000; Sharff et al., 2001). Each monomer of TolC contributes
four b-strands to formation of a 12-stranded b-barrel in the
outer membrane. Entrance to the TolC tunnel from the peri-
plasmic space is regulated by the iris-like aperture of the three
sets of a-helices (Andersen et al., 2002b).
The atomic structure of colicin E3 has been solved at 3.0 A˚
resolution (Fig. 1 D; Soelaiman et al., 2001). The N-terminal
(T), central coiled-coil (R), and C-terminal (C) domains are
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responsible for translocation across the outer membrane and
periplasmic space, for interaction with the BtuB receptor,
and for cytotoxic activity, respectively (Fig. 1 D). An
elongate (160 A˚ and 100 A˚) coiled-coil associated with the
R-domain is a prominent feature of the structures of colicins
Ia and E3 (Wiener et al., 1997; Soelaiman et al., 2001). The
recently solved structure of the complex of BtuB with the
colicin E3 135 residue receptor-binding coiled-coil domain
(Kurisu et al., 2003) did not show plug displacement from
the BtuB b-barrel, implying that colicin does not cross the
outer membrane through the BtuB barrel. The extended
length of the R-domain coiled-coil, and its oblique
orientation in the 2.75 A˚ x-ray structure suggest that the
function of its initial interaction with BtuB is to deliver the
colicin T- and C-domains (Fig. 1 D) to a secondary receptor-
translocator, which was implied to be OmpF (Benedetti et al.,
1989). It was suggested that OmpF provides the channel
through which unfolded domains of the colicin can pass into
the periplasm (Kurisu et al., 2003).
Translocation of colicins through OmpF channels should
cause occlusion of the channels that would be manifested by
a decrease in their ion conductance. In this study, such
a decrease in the conductance of OmpF channels in planar
bilayer membranes caused by colicins E3 and N was ob-
served. The asymmetry of this conductance decrease with
respect to the side of colicin addition, the polarity of a required
membrane potential, and localization of the interaction site in
the translocation domain of the colicins, implies that the
occlusion is speciﬁc to one side of the membrane-inserted
OmpF receptor. Similar speciﬁc occlusion of TolC channels
by colicin E1 was also observed. These data imply that BtuB
and OmpF or TolC are involved in a two-receptor mechanism
for colicin import through the E. coli outer membrane.
MATERIALS AND METHODS
Materials
Synthetic phospholipids, DOPC and DOPE (Avanti Polar Lipids, Alabaster,
AL), used for planar bilayer formation, were dissolved in chloroform.
Outer membrane proteins
BtuB was expressed in E. coli strain TNEO12 (pJC3) and puriﬁed as
described (Taylor et al., 1998; Kurisu et al., 2003), using 1.5% OG for
extraction and 0.1% LDAO during puriﬁcation. The same protocol was
successfully used for OmpF puriﬁcation from E. coli strain MH225
(pPR272) (Misra and Reeves, 1987). Purity and activity of OmpF (LPS
content was not measured) were comparable with protein puriﬁed according
to a protocol based on multiple extraction of membranes and puriﬁcation in
octyl-POE (Garavito and Rosenbusch, 1986; Hitscherich et al., 2000).
OmpF puriﬁed in LDAOwas transferred to 1% octyl-POE before it was used
for planar bilayer formation.
TolC was expressed in E. coli strain AG100 with the plasmid pTrc99A-
TolC under a strong IPTG-inducible promoter (Vakharia et al., 2001), and
puriﬁed by ion-exchange chromatography onQSepharose FF followedby gel
ﬁltration on Sephacryl S-300 as described previously (Koronakis et al., 1997).
Colicins and fragments
Colicins E1 (Zhang and Cramer, 1992), E3 (Herschman and Helinski, 1967),
and N (Cavard and Lazdunski, 1979; Izard et al., 1994) were prepared
according to existing protocols.
Point and deletion mutations in colicin E3 were made by cloning
respective PCR ampliﬁed products into the Nde1/XhoH1 sites of pET41b
vector DNA. Proteins were expressed in BL21 (DE3) cells and puriﬁed
using Ni-charged IDA-agarose column. Recombinant R-domain of colicin
E3, R135 (Kurisu et al., 2003); thermolytic fragments of colicin E1, P178,
and P342 (Ohno-Iwashita and Imahori, 1982); and colicin N, P205, and
P322 (Massotte and Pattus, 1989; Evans et al., 1996b) were prepared as
described. The C-terminal domain of colicin E3 with bound immunity (Imm)
protein was kindly provided by K. Jakes (Albert Einstein College of
Medicine, Bronx, NY). Truncated colicin E3 T-domain fragments were
obtained by digestion with thermolysin for 60 min at 37C at thermoly-
sin:colicin E3, 1:1000 (w/w). The C-terminal fragments of colicin N, 35 and
22 kDa, were obtained by digestion for 60 and 300 min at 37C at
thermolysin:colicin N ratios, 1:400 and 1:200 (w/w), respectively. The
N-terminal sequences and molecular mass of proteolytic fragments were
veriﬁed by the MALDI-MS analysis.
Planar bilayer membranes
Planar bilayer lipid membranes were formed on a 0.2 or 0.45 mm diameter
aperture in a partition separating two 1-ml compartments of the experimental
FIGURE 1 Ribbon diagrams of E. coli outer membrane proteins and
colicin E3. (A) Cobalamin receptor, BtuB (Chimento et al., 2003). (B) OmpF
trimer (Cowan et al., 1992). (C) TolC trimer (Koronakis et al., 2000). Top
and side views are shown with the b-barrel colored light blue, and the
N-terminal 132 residue plug domain of BtuB colored green. (D) Colicin E3
with bound immunity protein (Soelaiman et al., 2001). N-terminal
translocation (T), central coiled-coil BtuB-binding (R), and C-terminal
endonuclease (C) domains are colored green, red, and blue, respectively.
Imm protein, yellow.
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setup, using a 1:1 mixture (10 mg/ml) of DOPC and DOPE in n-decane, by
a brush technique (Mueller et al., 1962). The use of lipids dissolved in n-
decane for membrane formation was based on extension of other studies on
porins (Benz et al., 1985; Song et al., 1998). The aqueous solutions in
both compartments were 5 mM NaPi, pH 7.0, 0.1 M KCl, 23C. 0.1–2 ml
OmpF, 0.001–1 ng/ml in the buffer with 1% octyl-POEwere added to the cis-
compartment (less protein was added for membranes of larger area), and the
solution was magnetically stirred for 5–20 min until channels appeared. 1–2
ml TolC, 50 mg/ml, was added from the buffer with 1% octylglucoside. For
single-channel measurements, after OmpF channels were recorded, the cis-
chamber was perfused by 10 ml of the buffer solution to prevent new channel
incorporation into the membrane. The membrane electrical resistance was
not altered by addition of 1% OG or octyl-POE (10 ml). Colicins were added
to the cis- or trans-side of the membrane, and solutions in both chambers
were magnetically stirred for 5 min. The membrane current was measured in
voltage-clamp mode with Ag/AgCl electrodes, using a WARNER BC-525C
ampliﬁer (Warner Instruments, Hamden, CT). The transmembrane potential
was applied to the electrode on the cis-side of the membrane.
The efﬁciency of occlusion of OmpF channels by colicin E3 was
characterized by two parameters: tocc, duration of channel transition from
open to occluded state, measured as the interval of time between application
of the transmembrane potential and attainment of the steady-state of occlu-
sion; Focc, the fraction of time that channels are in the closed state measured
using channel histograms for t . tocc.
RESULTS
Binding of colicin E3 to BtuB does not displace
the plug domain from the b-barrel
To test for the existence of a signiﬁcant colicin-induced ion
conductance through BtuB that could be an indicator of
a polypeptide translocation channel, a planar bilayer
membrane was incubated with BtuB (5 mg/ml in the cis-
compartment) for 30 min. Addition of BtuB to the bilayer
membrane increased the current (transmembrane potential,
80 mV) from 0.23 6 0.40 pA to 0.55 6 0.39 pA at
a positive potential, and from 0.19 6 0.43 pA to 0.48 6
0.33 pA at negative potentials. These changes in current,
corresponding to conductance changes of 6 4 pS, are
within the range of current ﬂuctuations in the apparatus, and
can be attributed to an increase in ion leakage through the
lipid bilayer due to the presence of detergent in the BtuB
stock solution. Subsequent addition of colicin E3 or vitamin
B12 from either side of the membrane did not affect the
bilayer conductance.
Nonfacilitated diffusion of the large (50–60 kDa) and
water-soluble colicin molecules through the phospholipid-
lipopolysaccharide bilayer of the bacterial outer membrane
seems unlikely. The most probable candidates for colicin
translocators through the bacterial outer membrane would be
those outer membrane proteins for which there is structural
and/or electrophysiological evidence for a transmembrane
channel of adequate size. Two such proteins are OmpF
(Cowan et al., 1992) and TolC (Koronakis et al., 2000).
Mutation studies indicated a requirement of these proteins for
import of the group A colicins (Benedetti et al., 1989;
Lazzaroni et al., 2002).
Occlusion of OmpF by colicin E3
In 0.1 M KCl, OmpF incorporated into planar bilayers
yielded a single channel conductance of 300 6 20 pS at
negative and 260 6 20 pS at positive transmembrane
potentials per a monomer (Fig. 2, A and E). To prevent
channel closing in the presence of high transmembrane
potentials (voltage-gating) (Schindler and Rosenbusch,
1978; Phale et al., 1997), the applied transmembrane poten-
tials were not allowed to exceed a magnitude of 50 mV.
All three channels of the single OmpF trimer are mostly in an
open state with occasional closings, which were more
frequent at negative than at positive potentials (Fig. 2 A).
Colicin E3 induced the closing of the OmpF channels only
when it was added from the trans-side of the planar bilayer,
the side opposite to that of addition of OmpF (Fig. 2,B,C, and
E). This channel closing occurred at cis-negative potentials.
The rate and magnitude of the effect were dependent on
colicin E3 concentration in the bathing solution. With a
colicin concentration of 50 ng/ml (tocc . 100 s; Focc 24 6
11%, n ¼ 3; Table 1), the occlusion of the OmpF channels
was incomplete with a pattern of ﬂickering (Fig. 2 B).
Increasing the colicin E3 concentration to 500 ng/ml resulted
in complete occlusion of all or most channels, with tocc ¼
43 6 26 s; Focc ¼ 83 6 14%, n ¼ 11 (Fig. 2 C; Table 1).
Changing the sign of the potential to cis-positive opened all
channels, and switching back to a negative potential again
resulted in channel closing (Fig. 2 C, repeat 2), implying that
the voltage-induced occlusion is reversible. Removal of
unbound colicin E3 by perfusion of the trans-compartment
after application of the positive potential did not eliminate
channel occlusion (Fig. 2 C, repeat 3), demonstrating that the
colicin, which occludes OmpF at negative potentials, con-
tinues to be bound at positive potentials.
The efﬁciency of occlusion by negative potentials, and the
opening of occluded channels by positive, depends on the
magnitude of the potential (Fig. 2 D), as only partial closing
was observed at 20 mV; however, fast and complete
channel closing or opening takes place at 80 mV (Focc ¼
39% and 98% at 20 and 80 mV, respectively).
To elucidate the role of transmembrane potentials in
colicin E3 occlusion of OmpF, i.e., whether i), it facilitates
colicin binding to OmpF; or ii), a transmembrane potential is
required to translocate OmpF-bound colicin into the channel,
the trans-compartment was perfused after incubation for
5 min with colicin E3, (as in Fig. 2 C, but without application
of a transmembrane potential). This did not abolish sub-
sequent occlusion of OmpF channels by the previously
added colicin in the presence of the cis-negative potential
(not shown), implying that binding of the colicin does not
require the transmembrane potential. It was concluded that
the role of the potential is to translocate the bound colicin E3
into the OmpF channel lumen.
Colicin E3 added to the cis-compartment (2.4 mg/ml) did
not affect the OmpF channel conductance at positive or nega-
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tive transmembrane potentials (Focc¼ 0.3%; Fig. 3, A and B;
Table 1). Subsequent addition of colicin E3 (400 ng/ml) to
the trans-compartment induced OmpF channel closing at cis-
negative potentials (tocc ¼ 67 6 20 s; Focc ¼ 71 6 12%,
n ¼ 3, Fig. 3 C), showing that the presence of colicin E3 on
the cis-side does not perturb occlusion of OmpF from the
trans-side.
OmpF-occlusion site of colicin E3
It has been proposed that the N-terminal T-domain of colicins
(Fig. 1D, green) is responsible for interactions with the Omp
and Tol proteins that allow or facilitate colicins to cross the
outer membrane and periplasmic space (Bouveret et al.,
2002; Lazzaroni et al., 2002; Kurisu et al., 2003). To locate
the putative OmpF-binding site on the colicin, recombinant
and proteolytic fragments of colicin E3 (Fig. 4, A and B) were
examined for occlusion competence. Recombinant E3 frag-
ments containing residues 313–447 (R-domain), 455–551
(C-domain with bound Imm protein), and 289–551 (R- and
C-domains with bound Imm protein) added at concentrations
TABLE 1 Occlusion of OmpF and TolC by colicins occurs from
the trans-side of membrane
Receptor Colicin side concentration tocc s Focc (n) %
OmpF .100 24 6 11 (3)
Colicin E3 trans 50 ng/ml 43 6 26 83 6 14 (11)
500 ng/ml 12 6 9 0.3
cis 2.4 mg/ml 3 6 2 76 6 8 (4)
E3 T-domain trans 250 ng/ml 74 6 39 84 6 7 (4)
Colicin N trans 1 mg/ml 55 6 15 (7)
TolC
Colicin E1 trans 1 mg/ml
Transmembrane potential, 50 mV. Buffer, 5 mM NaPi, pH 7.0, 0.1 M
KCl.
FIGURE 2 Occlusion of OmpF channels by colicin
E3 from the trans-side of the membrane, driven by cis-
negative potential. (A) Transmembrane current (solid)
through OmpF channels (one trimer incorporated) at
a potential of 50 mV (dashed). OmpF, 10 pg/ml, added
to the cis-compartment. Solution, 5 mM NaPi, pH 7.0,
0.1 M KCl, was stirred until channels were detected
(;5 min), and then replaced by perfusion, as described
in Methods. The sign of the potential refers to the cis-
side of membrane. (B) Colicin E3, 50 ng/ml, was added
to the trans-compartment, and the record started after 5
min stirring. (C) Increasing the colicin E3 concen-
tration to 500 ng/ml increased rate of occlusion. Perfu-
sion of trans-compartment at 0 mV (after repeat 2) or
150 mV (not shown) does not abolish occlusion. (D)
Dependence of efﬁciency of occlusion and opening of
occluded OmpF channels on the magnitude of the
transmembrane potential. (E) Histogram of OmpF
channel conductance as a function of transmembrane
potential polarity in the absence and presence of colicin
E3 on the trans-side. Maximum conductance of OmpF
was 780 and 950 pS at 150 and 50 mV in the ab-
sence of colicin, and 780 and 10 pS at150 and50mV
in the presence of colicin E3, 500 ng/ml, on the trans-
side of membrane.
3904 Zakharov et al.
Biophysical Journal 87(6) 3901–3911
of 5–10 mg/ml from either side of the membrane, in the
presence of either sign of the transmembrane potential, did
not diminish or perturb the OmpF channel conductance (not
shown). However, the N-terminal segment of colicin E3,
residues 1–285 (T-domain, Fig. 4, A and B), showed efﬁcient
occlusion when added from the trans-side of membrane at
a cis-negative potential (tocc ¼ 12 6 9 s; Focc ¼ 76 6 8%,
n ¼ 4; Fig. 4 C, red histogram; Table 1), implying that the
OmpF-binding site of colicin E3 is located in the trans-
location domain. Addition of T-domain from the cis-side
caused only a transient closing of 1–2 OmpF channels
(Focc  6%, Fig. 4 D).
The N-terminal residues 1–83 of the colicin E3 T-domain,
which are presumably disordered because of high content
(42%) of glycine residues, were not resolved in the x-ray
structure of colicin E3 (Soelaiman et al., 2001). The rest of the
T-domain forms a compact globule (Soelaiman et al., 2001).
Proteolytic digestion of colicin E3 by thermolysin yielded
23,930 and 24,680 Da fragments (residues 81–310 and 84–
320), whose sequence was revealed by Edman degradation
and MALDI-MS. These fragments did not occlude OmpF
channels (tested at 10 mg/ml), implying that the OmpF
binding site is located within residues 1–80 in the N-terminal
segment.
The occlusion capability of colicin E3 was also lost in
truncated colicins E3 in which the N-terminal 50, 25, and 10
residues were deleted. This localizes the OmpF-occlusion
site of colicin E3 to residues 1–10, close to the N-terminus,
and excludes the ‘‘TolB box’’ (residues 35–42; Escuyer and
Mock, 1987; Bouveret et al., 1997) as a candidate for this
function. The amino acid sequence of residues 1–10 is: Met-
Ser-Gly-Gly-Asp-Gly-Arg-Gly-His-Asn. Taking into ac-
count that occlusion depends on transmembrane potential,
N-terminal charged residues, Asp-5 and Arg-7, were mutated
to Ala. The colicin E3 double mutant, D5A/R7A, was
inactive in occlusion (not shown), implying that the OmpF-
occlusion site of colicin E3 includes Asp-5 and/or Arg-7.
Occlusion of OmpF channels by colicin N
OmpF is the only outer membrane protein required for the
cytotoxicity of colicin N, which acts as both a cell surface
receptor and the translocation pathway (Benedetti et al.,
1989).
Colicin N (1 mg/ml) added from the cis-side of the planar
bilayer did not occlude OmpF channels (Fig. 5 A). However,
like colicin E3, it occluded efﬁciently from the trans-side
(tocc, 3 6 2. s; Focc, 84 6 8%, n ¼ 7; Fig. 5 B; Table 1), de-
monstrating fast closing of most OmpF channels at negative
potentials. These channels opened at positive potentials.
However, for complete opening of all occluded OmpF chan-
nels, a larger potential, (180 mV) was required (not shown).
Proteolytic digestion of colicin N by thermolysin produces
two fragments, 35,250 Da (residues 66–387) and 22,320 Da
(residues 183–387) (Fig. 5 C), which contain the R-C and
C-domains, respectively (Massotte and Pattus, 1989; Evans
et al., 1996c; Vetter et al., 1998). These fragments did not
affect OmpF channel conductance from either side of the
FIGURE 3 Colicin E3 does not occlude OmpF
channels from the cis-side of the membrane. (A).
Transmembrane current through OmpF channels (two
trimers are incorporated) at a transmembrane potential
of 50 mV (dashed). OmpF added to cis-compartment.
(B) Colicin E3 (2.4 mg/ml) was added to the cis-
compartment. Record started after 5 min stirring, and
a transmembrane potential of 50 mV was applied. (C)
Colicin E3 added to the trans-side (400 ng/ml) in the
presence of cis-side colicin.
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planar bilayer (not shown). This implies that i), the OmpF
binding site of colicin N is located in an N-terminal peptide,
residues 1–65, that contains the T-domain; and ii), any
possible binding of colicin N through the C- or R-domains
(Evans et al., 1996a; Stora et al., 1999; Dover et al., 2000) is
not associated with OmpF channel occlusion.
Interaction of colicins E3 and N with OmpF,
resulting in channel occlusion, is dependent
upon electrostatic forces
All of the experiments described above were carried out in
0.1 M KCl on both sides of planar bilayer. Increasing the salt
FIGURE 4 OmpF channel occlusion by the T domain of colicin E3. (A)
Colicin E3 fragments used to infer location in colicin polypeptide of OmpF-
binding site. ‘‘E3-10’’, colicin E3 with N-terminal 10 residues deleted.
Fragments labeled by His6 were His-tagged. (B) SDS-PAGE of colicin
E3 and its recombinant fragments. (Lanes) 1, protein molecular weight
standards; 2, intact colicin E3 with Imm; 3, RC-fragment (residues 289–551)
with Imm; 4, C-fragment (residues 455–551) with Imm; 5, T-domain
(residues 1–255); 6, R-domain (residues 313–447); and 7, truncated
T-domain (residues 84–315). (C) Histograms of the OmpF channel conductance
without added T-domain at 150 mV (blue) and 50mV (green), and with
T-domain (residues 1–285), 0.1mg/ml, in the trans-compartment at150mV
(black) and 50mV (red). (D) Histograms of OmpF channel conductance
without added T-domain at 150 mV (blue) and 50mV (green), and with
T-domain (residues 1–285), 0.1 mg/ml, in the cis-compartment at 150 mV
(black) and 50mV (red). Buffer, 5 mM NaPi, pH 7.0, 0.1 M KCl.
FIGURE 5 Occlusion of OmpF channels by colicin N. (A) Colicin N in
the cis-compartment, 1 mg/ml, does not affect the current through OmpF
channels. (B) Subsequent addition of colicin N in the trans-compartment
induces fast OmpF channel closings at the negative transmembrane
potential. The change in the magnitude of transmembrane potential is
shown by dashed line. (C) SDS-PAGE of colicin N fragments obtained by
proteolytic digestion by thermolysin. (Lanes) 1, molecular weight protein
standards; 2, colicin N; 3, 22,320 Da fragment; and 4, 35,250 Da fragment.
Molecular mass of fragments was determined by MALDI mass-spectros-
copy.
TABLE 2 Occlusion of OmpF channels by colicins is abolished
by high salt concentration in bath solution
Focc (n ¼ 3) %
KCl, M Colicin E3 Colicin N
0.1 91 6 6 88 6 5
0.3 ca. 0.1 4 6 3
1.0 ,0.1 ,0.1
Colicins, 1 mg/ml, were added to the trans-compartment. Transmembrane
potential, 50 mV. Solutions in both compartments were buffered with
5 mM NaPi, pH 7.0.
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concentration to 1.0 M entirely prevents occlusion of OmpF
channels by colicins E3 and N (Table 2). At 0.3 M salt, only
transient closing was observed in the presence of colicin N
(Table 2). This implies that electrostatic interactions between
colicins E3 or N and OmpF are necessary for channel
occlusion.
Colicin E1 (20 mg/ml) did not affect the OmpF channel
conductance (tested at 20 mg/ml; not shown). This is in
agreement with previous studies that showed import of this
colicin is not dependent on OmpF, but on the outer
membrane proteins, BtuB (Di Masi et al., 1973; Bradbeer
et al., 1976) and TolC (Nagel de Zwaig and Luria, 1967;
Davies and Reeves, 1975).
TolC channels in planar bilayers are occluded by
colicin E1, but not colicin E3
In the planar bilayer experiments, TolC shows an asymmetric
channel conductance that is dependent on transmembrane
potential polarity, with a main conductance state of 80 pS at
cis-positive potentials in 1MKCl, pH 7.0, and 20 pS in 0.1M
KCl (Andersen et al., 2002a). In addition to the dominant
80 pS state, substates with conductance of 10, 20, and 30 pS
at 1M KCl have been reported (Andersen et al., 2002a).
The effect of colicin E1 on TolC channel conductance was
tested in multichannel experiments (Fig. 6). TolC was added
to the cis-side of the planar bilayer, and after stirring for 20–
30 min, current was measured in the presence of positive or
FIGURE 6 Effect of colicin E1 on TolC channels.
(A) TolC (0.5 ng/ml) was added to the cis-side of the
planar membrane, and solutions were stirred for
20 min. Channel current was measured after perfusion
of the cis-compartment with 5 ml of buffer at trans-
membrane potentials of 50mV (dashed line). Buffer in
both compartments, 5 mM KPi, pH 7.0, 0.1 M KCl,
23C. (B) After colicin E1 (1 mg/ml) was added to the
trans-side, solutions were stirred for 5 min, and
channel current measured again. Perfusion of trans-
compartment resulted in abolishment of TolC channel
occlusion at negative potentials. (C) Colicin E1, 5 mg/
ml, in the cis-compartment does not occlude TolC
channels. (D) TolC channel conductance histograms
before and after addition of colicin E1. Conductance
values for the histogram were measured when the
current of occluded channels was stabilized (t . tocc),
;70 s after switching the potential to 50 mV.
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negative transmembrane potentials (Fig. 6 A). Colicin
E1 added from the trans-side of the membrane decreased
the TolC channel current in the presence of negative
potentials (tocc ¼ 74 6 39 s; Focc ¼ 55 6 15%, n ¼ 7;
Table 1; Fig. 6, A, B, and D), and did not have any effect at
positive potentials. The same extent of channel closing was
observed after the potential was switched to positive, and
then to negative potential (Fig. 6 B). Perfusion of the trans-
compartment abolishes the occlusion of TolC channels (Fig.
6 B), implying that, in contrast to the colicin E3 interaction
with OmpF, colicin E1 dissociates from TolC in the absence
of a cis-negative potential.
Colicin E1 added to the cis-side of the membrane bilayer
did not occlude TolC channels at negative or positive
potentials (Fig. 6 C). Colicins E3 (16 mg/ml) or N (4 mg/ml)
added to the cis- or trans-side of the membrane bilayer did
not occlude TolC channels at any transmembrane potential
(not shown).
To ﬁnd out which domain of the colicin E1 is responsible
for interactions with TolC, proteolytic fragments of colicin
E1 were tested for their ability to occlude. Thermolysin
digests colicin E1 from the N-terminus leaving the
C-terminal domain intact (Dankert et al., 1982). Thermolytic
fragments, P178 (residues 345–522) and P342 (residues 181–
522) that include C-domain and CR-domains, respectively,
were characterized previously (Dankert et al., 1982; Ohno-
Iwashita and Imahori, 1982; Griko et al., 2000). Addition of
these fragments (10 mg/ml) to either bilayer compartment did
not occlude TolC channels at either polarity of the trans-
membrane potential (not shown). This implies that the
N-terminal segment, residues 1–180, containing the T-domain,
mediates the interaction of colicin E1 with TolC.
DISCUSSION
Components of the colicin cellular import system
The BtuB receptor for colicins E3 and E1 in the outer
membrane (Fig. 1 A) is a b-barrel protein plugged by a 132
residue globular N-terminal domain (Chimento et al., 2003).
The major axes of the b-barrel pore are 27–33 A˚, which
would be sufﬁcient, if not plugged, for translocation of
unfolded and partially folded domains of colicin molecules.
Taking into account the highly elongate shape of colicins E3
(Fig. 1D) and Ia (Wiener et al., 1997), this initially suggested
the possibility of colicin entry into the cell through the pore of
the BtuB barrel (the ‘‘nail’’ hypothesis, reviewed in Cao and
Klebba, 2002). This hypothesis has been abandoned because:
i), the x-ray structure of the R135-BtuB complex showed that
the receptor binding domain of colicin E3 hardly penetrates
the extracellular loop region of BtuB (Kurisu et al., 2003);
and ii), electrophysiological measurements provided no
evidence for colicin translocation of BtuB. Alternatively, it
was proposed that BtuB functions as the initial high afﬁnity
receptor for colicin E3 (Kd  109 M for the engineered
R135 receptor-binding domain (Kurisu et al., 2003); Kd 
1011 M for the intact colicin (Imajoh et al., 1982)). The
initial binding converts the three-dimensional search by the
colicin for cell entry into a 2-dimensional search on the
membrane surface for a second outer membrane protein that
can function as a translocator. The extended coiled-coil
anchored on BtuB (Fig. 1 D), and the disordered 83 residues
at the N-terminus of colicin E3 (Soelaiman et al., 2001)
provide the equipment needed to ‘‘ﬁsh’’ for the translocator
(Fig. 7).
The OmpF porin is a prominent candidate for the second
outer membrane protein in the colicin translocation pathway
of colicin E3 because of the known requirement of the OmpF
gene product for cytotoxicity (Benedetti et al., 1989), its high
abundance in the OM (Nikaido and Vaara, 1987; Nikaido,
2003), and its relatively large ion channel (Cowan et al.,
1992).
Occlusion of OmpF and TolC channels by
colicins of group A
Colicins E3 and N occluded OmpF (Figs. 2 and 5), and
colicin E1 occluded TolC channels (Fig. 6). The properties of
these occlusion effects were: i), they were unidirectional, i.e.
each colicin occluded only from the trans-side of the planar
bilayer relative to the side (cis) of OmpF addition to the
bilayer; ii), the occlusion required a transmembrane potential,
negative on the side opposite to that of colicin addition; iii),
occluded channels were opened by a positive potential; and
iv), an increase in salt concentration of the buffer solution
prevented occlusion (Table 2), implying that the colicin-porin
interactions that cause occlusion are primarily electrostatic.
FIGURE 7 Two-receptor model of colicin cellular import. X-ray
structures of colicin E3 (Soelaiman et al., 2001), and of its 135 residue
receptor-binding domain (red) in complex with BtuB (Kurisu et al., 2003),
are superimposed to show the position of the translocation domain (blue)
proposed to extend its N-terminus through the OmpF trimer (Cowan et al.,
1992). The x-ray structure of colicin Ia (Wiener et al., 1997) was used to
model colicin E1 in its interaction with TolC (Koronakis et al., 2000).
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Occlusion of OmpF by colicins is similar to alteration of
porin channels by polyamines that resulted in the stabiliza-
tion of channel closed states (Iyer and Delcour, 1997). Effects
of polyamines are concentration- and potential-dependent,
but unlike colicins, they modulate porin channels from both
sides of membranes, interacting with the porin eyelet
(Samartzidou and Delcour, 1999; Samartzidou et al., 2003).
The polyamines protect susceptible cells from colicin action
(Bredin et al., 2003).
Interaction of the colicin translocation domain
with the outer membrane receptor-translocator
Presently, a detailed understanding of the functions of the
N-terminal translocation domain of colicins that enable their
import across the cell envelope is not available. It is known
that the N-terminal domains of E3 and E1 interact with the
periplasmic TolB (Escuyer and Mock, 1987; Bouveret et al.,
1997) and TolA (Benedetti et al., 1991; Derouiche et al.,
1997) proteins, respectively. This study shows that one
function is to interact with the outer membrane OmpF
(colicins E3 and N) and TolC (colicin E1) receptor-trans-
locators, as shown by occlusion of the ion channel
conductance of these OM proteins. In the case of colicin E3,
occlusion of OmpF conductance has been localized to the
N-terminal residues 5–7. The ‘‘TolB box’’ of colicin E3, located
between residues 35 and 42, which interacts with TolB in the
periplasm, and which is thereby required for colicin E3
translocation (Escuyer and Mock, 1987; Bouveret et al.,
1997), is not required for occlusion of OmpF channels.
Requirement of negative transmembrane potential
The requirement of a negative transmembrane potential for
occlusion seems to contradict the view that there is no
signiﬁcant electrical potential gradient across the bacterial
outer membrane (Nikaido and Vaara, 1987). This view is
based on the abundance (.105 molecules of OmpF per
E. coli cell) of highly conductive porins in these membranes.
However, occlusion of OmpF and TolC by colicins, unlike
voltage-gating of OmpF, does not requires a high potential
and occurs at 20 mV (Fig. 2 D).
An additional source of the electrical ﬁeld necessary for
colicin occlusion could be the asymmetric distribution of
phospholipid and LPS in the outer membrane. Phospholipid
forms the periplasmic leaﬂet of OM, and the outer layer
consists mostly of LPS (Kamio and Nikaido, 1976; Nikaido,
2003). This may generate surface and dipole potentials of
signiﬁcant magnitude in the outer membrane that results in
a potential difference between the phospholipid and LPS
monolayers of 40–80 mV, negative on the side (periplasmic)
of the phospholipid. Such a potential was measured in
asymmetric planar LPS/phospholipid bilayers (Seydel et al.,
1992; Wiese et al., 1994, 1996). Cationic species could be
driven through pores in the electrical ﬁeld generated by such
a potential gradient. In case of long polypeptides, this would
be possible only if they ﬁrst bind speciﬁcally and then enter
the pore.
Translocon model of colicin import
The oblique orientation (40 relative to the membrane plane
(Kurisu et al., 2003) of the 135 residue 100 A˚-long R-domain
bound to BtuB implies that when the entire colicin E3 is
bound to BtuB, its C-terminal cytotoxicity (C) and
N-terminal translocation (T) domains are well separated from
BtuB, and the T-domain projects close the membrane
surface, 50–100 A˚ from BtuB (Fig. 7). The abundance of
OmpF in the E. coli outer membrane, .105 molecules per
cell (Nikaido and Vaara, 1987), implies that ;1 OmpF will
be found on the surface of a 1-mm diameter cell at 100-A˚
spacings. The disordered N-terminal T-domain of colicin E3
(Fig. 7) can then search for a thermodynamically favorable
binding site at the entrance to the aperture of its channel
lumen (7 A˚ 3 11 A˚; Cowan et al., 1992). BtuB, OmpF, and
colicin E3 could form a translocon to move the colicin T- and
C-domains across the outer membrane. A similar translocon
could be formed by BtuB, TolC, and colicin E1 (Fig. 7). This
is in agreement with genetic studies showing that cellular
import of colicin E1 on the one hand, and colicins A, E3, and
N on the other, is dependent on the presence of tolC and
ompF gene products (Nagel de Zwaig and Luria, 1967;
Davies and Reeves, 1975; Benedetti et al., 1989; Bourdi-
neaud et al., 1990; Koronakis et al., 1997).
Translocation of colicins through porin receptors would
require unfolding of the translocated domains of colicins. In
this context, the partial unwinding of the coiled-coil termini
of receptor-binding domain of colicin E3, which was detected
in the x-ray structure of the BtuB-R-domain structure (Kurisu
et al., 2003), could be considered as an initial step in colicin
unfolding which is triggered by the colicin-BtuB interaction.
The interactions of components of the periplasmic and inner
membrane Tol system with porins or directly with the
inserted colicins could provide another source of energy, as
could potential-dependent threading of the colicin across the
outer membrane through OmpF or TolC.
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